JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 15, Issue 4 (2023)
Iran J War Public Health 2023, 15(4): 361-367 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/10/12 | Accepted: 2023/11/11 | Published: 2023/11/26
Received: 2023/10/12 | Accepted: 2023/11/11 | Published: 2023/11/26
How to cite this article
Ghafil F, Hassan E, Aziz N, Salim M, Majeed S, Rasheed S et al . Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia. Iran J War Public Health 2023; 15 (4) :361-367
URL: http://ijwph.ir/article-1-1405-en.html
URL: http://ijwph.ir/article-1-1405-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia
Authors
F.A. Ghafil1, E.S. Hassan *1, N.D. Aziz2, M.M. Salim3, S.A. Majeed1, S.M.H. Rasheed4, H.W. Mardan5
1- Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq
2- Department of Clinical Pharmacy, Collage of Pharmacy, University of Kerbala, Kerbala, Iraq
3- Department of Clinical Pathology, Faculty of Medicine, University of Kufa, Najaf, Iraq
4- Department of Clinical Microbiology, Faculty of Medicine, University of Kufa, Najaf, Iraq
5- Middle Euphrates Center of Neurosciences, Al-Sadder Teaching Hospital, Al-Najaf Al-Ashraf Health Directorate, Najaf, Iraq
2- Department of Clinical Pharmacy, Collage of Pharmacy, University of Kerbala, Kerbala, Iraq
3- Department of Clinical Pathology, Faculty of Medicine, University of Kufa, Najaf, Iraq
4- Department of Clinical Microbiology, Faculty of Medicine, University of Kufa, Najaf, Iraq
5- Middle Euphrates Center of Neurosciences, Al-Sadder Teaching Hospital, Al-Najaf Al-Ashraf Health Directorate, Najaf, Iraq
Abstract (375 Views)
Aims: The study aimed to assess the cardioprotective potential of celastrol against cardiac injury induced by sepsis via amelioration of IL6, TNF, TLR4, IL10, F2-isoprostane, cardiac troponin, and CK-MB, as well as at histological level.
Materials & Methods: Twenty-four Swiss albino mice aged between 6 and 8 weeks, weighted between 20 and 30g, were included and were randomly divided into four groups; Sham, Sepsis (laparotomy with CLP), Vehicle (treated with the equivalent volume of DMSO), and celastrol (treated with 2mg/kg IP 1hr before CLP) groups. By spectrophotometric assay, blood samples were then aspirated for cardiac troponin and CK-MB assessment. Part of the cardiac tissue was used to assess the levels of TNFα, IL6, IL10, F2-Isoprostane, and TLR4 by ELISA method; another part was used to assess the degree of cardiac tissue damage by histopathological analysis.
Findings: Significant cardiac damage was noticed in the sepsis group (p≤0.05) as compared with the sham group, manifested by a significant elevation in inflammatory markers (TNFα, IL6, TLR4) and oxidative stress marker (F2-Isoprostane) as well as cardiac troponin and CK-MB, with a significant reduction in IL10. Pretreatment with celastrol resulted in a significant reduction in TNF, IL6, TLR4, F2-Isoprostane, troponin, and CK-MB with significant elevation in IL10 compared to the sepsis group. In the same manner, significant histological damage was encountered in the sepsis group compared to the sham group, while the celastrol-treated group exhibited minor histological damage compared to the sepsis group.
Conclusion: Celastrol has cardio-protective effects against cardiac injury induced by endotoxemia.
Materials & Methods: Twenty-four Swiss albino mice aged between 6 and 8 weeks, weighted between 20 and 30g, were included and were randomly divided into four groups; Sham, Sepsis (laparotomy with CLP), Vehicle (treated with the equivalent volume of DMSO), and celastrol (treated with 2mg/kg IP 1hr before CLP) groups. By spectrophotometric assay, blood samples were then aspirated for cardiac troponin and CK-MB assessment. Part of the cardiac tissue was used to assess the levels of TNFα, IL6, IL10, F2-Isoprostane, and TLR4 by ELISA method; another part was used to assess the degree of cardiac tissue damage by histopathological analysis.
Findings: Significant cardiac damage was noticed in the sepsis group (p≤0.05) as compared with the sham group, manifested by a significant elevation in inflammatory markers (TNFα, IL6, TLR4) and oxidative stress marker (F2-Isoprostane) as well as cardiac troponin and CK-MB, with a significant reduction in IL10. Pretreatment with celastrol resulted in a significant reduction in TNF, IL6, TLR4, F2-Isoprostane, troponin, and CK-MB with significant elevation in IL10 compared to the sepsis group. In the same manner, significant histological damage was encountered in the sepsis group compared to the sham group, while the celastrol-treated group exhibited minor histological damage compared to the sepsis group.
Conclusion: Celastrol has cardio-protective effects against cardiac injury induced by endotoxemia.